Author: World Health OrganizationPublisher: World Health Organization
ISBN: 9240053735
Category : Medical
Languages : en
Pages : 26
Book Description
Report of the third meeting of the WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases
Author: World Health OrganizationPublisher: World Health Organization
ISBN: 9240053735
Category : Medical
Languages : en
Pages : 26
Book Description
Report of the sixth meeting of the WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases, Geneva, Switzerland, 14–15 February 2024
Author: World Health OrganizationPublisher: World Health Organization
ISBN: 9240094784
Category : Medical
Languages : en
Pages : 36
Book Description
The Diagnostic Technical Advisory Group (DTAG) for the WHO Global NTD Programme was formed to foster a unified approach for identifying and prioritizing diagnostic needs, and to inform WHO strategies and guidance on NTD diagnostics. The first meeting of the DTAG was held at the Inter Parliamentary Union in Geneva, Switzerland, in October 2019. The second took place virtually in October 2020, the third in June 2021, the fourth in October 2021 and the fifth in November 2022. Several disease-specific and cross-cutting DTAG subgroups have been formed, resulting in the development of target product profiles (TPPs) for new diagnostics, some of which have been published, and some of which are in production. WHO/NTD convened the sixth DTAG meeting on 14 and 15 February 2024, with the following objectives across the end-to-end process of diagnostic development: -consider updates from disease-specific subgroups and TPP production; -discuss progress made by the cross-cutting and resource mobilization subgroups; -discuss the Expert Review Panel for Diagnostics (ERPD) NTD pilot project and lessons learnt; -discuss engagement of manufacturers and developers; -discuss laboratory capacity strengthening and standardization of molecular methods; -deliberate on the priority/focus areas of engagement for the DTAG for the next 2 years.
Report of the fourth meeting of the WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases
Author: World Health OrganizationPublisher: World Health Organization
ISBN: 9240053751
Category : Medical
Languages : en
Pages : 22
Book Description
Report of the fifth meeting of the WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases
Author: World Health OrganizationPublisher: World Health Organization
ISBN: 9240075577
Category : Medical
Languages : en
Pages : 24
Book Description
The fifth meeting of the WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases (DTAG) was held in November 2022. The DTAG was established in 2019 to address gaps in NTD diagnostics through a harmonized approach for identifying and prioritizing diagnostic needs, and to inform WHO strategies and guidance on NTD diagnostics. The meeting addressed the end-to-end process of diagnostic development, including regulatory pathways, as we all as advocacy and resource mobilization, and engagement of diagnostics manufacturers and developers. The DTAG and its disease-specific and cross-cutting subgroups have supported and facilitated the development of several target product profiles for selected NTDs to address the critical diagnostic gaps.
Report of the first meeting of the WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases, Geneva, Switzerland, 30–31 October 2019
Author: World Health OrganizationPublisher: World Health Organization
ISBN: 9240003592
Category : Medical
Languages : en
Pages : 32
Book Description
Investing to Overcome the Global Impact of Neglected Tropical Diseases
Author: World Health OrganizationPublisher: World Health Organization
ISBN: 9241564865
Category : Medical
Languages : en
Pages : 211
Book Description
"The presence, or absence, of neglected tropical diseases (NTDs) can be seen as a proxy for poverty and for the success of interventions aimed at reducing poverty. Today, coverage of the public-health interventions recommended by the World Health Organization (WHO) against NTDs may be interpreted as a proxy for universal health coverage and shared prosperity - in short, a proxy for coverage against neglect. As the world's focus shifts from development to sustainable development, from poverty eradication to shared prosperity, and from disease-specific goals to universal health coverage, control of NTDs will assume an important role towards the target of achieving universal health coverage, including individual financial risk protection. Success in overcoming NTDs is a "litmus test" for universal health coverage against NTDs in endemic countries. The first WHO report on NTDs (2010) set the scene by presenting the evidence for how these interventions had produced results. The second report (2013) assessed the progress made in deploying them and detailed the obstacles to their implementation. This third report analyses for the first time the investments needed to achieve the scale up of implementation required to achieve the targets of the WHO Roadmap on NTDs and universal coverage against NTDs. INVESTING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES presents an investment strategy for NTDs and analyses the specific investment case for prevention, control, elimination and eradication of 12 of the 17 NTDs. Such an analysis is justified following the adoption by the Sixty-sixth World Health Assembly in 2013 of resolution WHA6612 on neglected tropical diseases, which called for sufficient and predictable funding to achieve the Roadmap's targets and sustain control efforts. The report cautions, however, that it is wise investment and not investment alone that will yield success. The report registers progress and challenges and signals those that lie ahead. Climate change is expected to increase the spread of several vector-borne NTDs, notably dengue, transmission of which is directly influenced by temperature, rainfall, relative humidity and climate variability primarily through their effects on the vector. Investments in vector-borne diseases will avoid the potentially catastrophic expenditures associated with their control. The presence of NTDs will thereby signal an early warning system for climate-sensitive diseases. The ultimate goal is to deliver enhanced and equitable interventions to the most marginalized populations in the context of a changing public-health and investment landscape to ensure that all peoples affected by NTDs have an opportunity to lead healthier and wealthier lives."--Publisher's description.
Report of the third meeting of the WHO Technical Advisory Group on Arboviruses (TAG-Arbovirus)
Author: World Health OrganizationPublisher: World Health Organization
ISBN: 9240095837
Category : Medical
Languages : en
Pages : 38
Book Description
In March 2022, the World Health Organization launched the Global Arbovirus Initiative, focusing initially on Aedes-borne arboviral diseases, to strengthen the coordination, communication, capacity-building, research, and the preparedness and response necessary to mitigate the growing risk of epidemics due to arboviral diseases. WHO established an independent and multidisciplinary group of experts, formalized under the name Technical Advisory Group on Arbovirus (TAG-Arbovirus), that meets to discuss and analyze the impact of arboviruses globally and provide technical, scientific and strategic considerations on arboviruses and the Global Arbovirus Initiative. The TAG-Arbovirus, supported by the WHO Arbovirus Secretariat, met in person from 20-22 June 2023 in Accra, Ghana, to provide technical feedback and advice on the priority activities of the Global Arbovirus Initiative moving forward. The meeting focused on the first pillar of monitoring risk and anticipation and included a technical review of the integrated arbovirus risk models and maps under development for WHO. The TAG also discussed priority gaps and opportunities for each of the most affected WHO regions, detection strategies for arboviruses across regional and member state endemic profiles and resource capacities, design and implementation of global data systems for arboviruses, the role of genomic surveillance, and the critical importance of risk communication and community engagement.
Report of the third meeting of the WHO Onchocerciasis Technical Advisory Subgroup, Geneva, Switzerland, 26-28 February 2019
Author: World Health OrganizationPublisher: World Health Organization
ISBN: 924000663X
Category : Medical
Languages : en
Pages : 49
Book Description
Target product profile for the development of a point-of-care diagnostic test for dermal leishmaniases
Author: Publisher: World Health Organization
ISBN: 9240045228
Category : Medical
Languages : en
Pages : 14
Book Description
Report of the fifth WHO stakeholders meeting on gambiense and rhodesiense human African trypanosomiasis elimination, Geneva, Switzerland, 7-9 June 2023
Author: World Health OrganizationPublisher: World Health Organization
ISBN: 9240091238
Category : Medical
Languages : en
Pages : 111
Book Description
Concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypanosomiasis (HAT). As a consequence, the disease was targeted for elimination as a public health problem by 2020. The Sixty-sixth World Health Assembly endorsed this goal in resolution WHA66.12 on Neglected tropical diseases, adopted in 2013. National sleeping sickness control programmes (NSSCPs) are core to progressing in the control of the disease and in adapting to the different epidemiological situations. The involvement of different partners, as well as the support and trust of long-term donors, has been crucial for these achievements. More than 20 years of partnership among WHO, Sanofi and Bayer have enabled WHO to strengthen and sustain financial, technical and material support for the implementation of control activities in countries where HAT is endemic. The long-term support from the Government of Belgium, the Bill & Melinda Gates Foundation (BMGF) and other research institutions in the Democratic Republic of the Congo (DRC) has also been essential. WHO convened the fifth stakeholders meeting on the elimination of HAT due to infection with Trypanosoma brucei gambiense (g-HAT) and Trypanosoma brucei rhodesiense (r-HAT) in Geneva, Switzerland, on 7–9 June 2023. The meeting was held again in person after the coronavirus disease (COVID-19) pandemic and jointly for both forms of the disease. The previous meetings on g-HAT held in 2014, 2016 and 2018, as well as on r-HAT in 2015, 2017 and 2019, and jointly for g-HAT and r-HAT in 2021 (8) reinforced the partnership and commitment for HAT elimination and structured the mechanisms of collaboration within the WHO network for HAT elimination. The network includes NSSCPs, groups developing new tools, international and nongovernmental organizations involved in disease control, and donors. Fewer than 1000 cases of HAT annually have been reported over the past 5 years, which is a historic achievement. The area at risk has been substantially reduced. The elimination of HAT as a public health problem at the global level has been achieved. The new road map for neglected tropical diseases (NTDs) 2021−2030 (“the road map”) with the target to interrupt the transmission of g-HAT requires the strengthened and sustained efforts of all stakeholders, national authorities and partners, under WHO coordination. It will take disproportionally high efforts and innovative strategies to find the last cases of g-HAT and neutralize its transmission. Given the limited resources and other competing public health priorities, this is a challenge that requires our joint commitment.